Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-25

Clinical Trial Update: Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 trial completed comparing carbetocin with oxytocin in elective cesarean sections for women at high risk of postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Ghamra Military Hospital | Conditions: Postpartum Hemorrhage | Phase 4 | Status: COMPLETED